Exploring the biological mechanisms of severe COVID-19 in the elderly: Insights from an aged mouse model
The elderly population, who have increased susceptibility to severe outcomes, have been particularly impacted by the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), leading to a global health crisis. However, definitive parameters or mechan...
Saved in:
Published in | Virulence Vol. 16; no. 1; p. 2487671 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Taylor & Francis
01.12.2025
Taylor & Francis Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The elderly population, who have increased susceptibility to severe outcomes, have been particularly impacted by the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), leading to a global health crisis. However, definitive parameters or mechanisms underlying the severity of COVID-19 in elderly people remain unclear. Thus, this study seeks to elucidate the mechanism behind the increased vulnerability of elderly individuals to severe COVID-19. We employed an aged mouse model with a mouse-adapted SARS-CoV-2 strain to mimic the severe symptoms observed in elderly patients with COVID-19. Comprehensive analyses of the whole lung were performed using transcriptome and proteome sequencing, comparing data from aged and young mice. For transcriptome analysis, bulk RNA sequencing was conducted using an Illumina sequencing platform. Proteomic analysis was performed using mass spectrometry following protein extraction, digestion, and peptide labelling. We analysed the transcriptome and proteome profiles of young and aged mice and discovered that aged mice exhibited elevated baseline levels of inflammation and tissue damage repair. After SARS-CoV-2 infection, aged mice showed increased antiviral and inflammatory responses; however, these responses were weaker than those in young mice, with significant complement and coagulation cascade responses. In summary, our study demonstrates that the increased vulnerability of the elderly to severe COVID-19 may be attributed to an attenuated antiviral response and the overactivation of complement and coagulation cascades. Future research on antiviral and inflammatory responses is likely to yield treatments that reduce the severity of viral respiratory diseases in the elderly. |
---|---|
AbstractList | The elderly population, who have increased susceptibility to severe outcomes, have been particularly impacted by the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), leading to a global health crisis. However, definitive parameters or mechanisms underlying the severity of COVID-19 in elderly people remain unclear. Thus, this study seeks to elucidate the mechanism behind the increased vulnerability of elderly individuals to severe COVID-19. We employed an aged mouse model with a mouse-adapted SARS-CoV-2 strain to mimic the severe symptoms observed in elderly patients with COVID-19. Comprehensive analyses of the whole lung were performed using transcriptome and proteome sequencing, comparing data from aged and young mice. For transcriptome analysis, bulk RNA sequencing was conducted using an Illumina sequencing platform. Proteomic analysis was performed using mass spectrometry following protein extraction, digestion, and peptide labelling. We analysed the transcriptome and proteome profiles of young and aged mice and discovered that aged mice exhibited elevated baseline levels of inflammation and tissue damage repair. After SARS-CoV-2 infection, aged mice showed increased antiviral and inflammatory responses; however, these responses were weaker than those in young mice, with significant complement and coagulation cascade responses. In summary, our study demonstrates that the increased vulnerability of the elderly to severe COVID-19 may be attributed to an attenuated antiviral response and the overactivation of complement and coagulation cascades. Future research on antiviral and inflammatory responses is likely to yield treatments that reduce the severity of viral respiratory diseases in the elderly. The elderly population, who have increased susceptibility to severe outcomes, have been particularly impacted by the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), leading to a global health crisis. However, definitive parameters or mechanisms underlying the severity of COVID-19 in elderly people remain unclear. Thus, this study seeks to elucidate the mechanism behind the increased vulnerability of elderly individuals to severe COVID-19. We employed an aged mouse model with a mouse-adapted SARS-CoV-2 strain to mimic the severe symptoms observed in elderly patients with COVID-19. Comprehensive analyses of the whole lung were performed using transcriptome and proteome sequencing, comparing data from aged and young mice. For transcriptome analysis, bulk RNA sequencing was conducted using an Illumina sequencing platform. Proteomic analysis was performed using mass spectrometry following protein extraction, digestion, and peptide labelling. We analysed the transcriptome and proteome profiles of young and aged mice and discovered that aged mice exhibited elevated baseline levels of inflammation and tissue damage repair. After SARS-CoV-2 infection, aged mice showed increased antiviral and inflammatory responses; however, these responses were weaker than those in young mice, with significant complement and coagulation cascade responses. In summary, our study demonstrates that the increased vulnerability of the elderly to severe COVID-19 may be attributed to an attenuated antiviral response and the overactivation of complement and coagulation cascades. Future research on antiviral and inflammatory responses is likely to yield treatments that reduce the severity of viral respiratory diseases in the elderly.The elderly population, who have increased susceptibility to severe outcomes, have been particularly impacted by the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), leading to a global health crisis. However, definitive parameters or mechanisms underlying the severity of COVID-19 in elderly people remain unclear. Thus, this study seeks to elucidate the mechanism behind the increased vulnerability of elderly individuals to severe COVID-19. We employed an aged mouse model with a mouse-adapted SARS-CoV-2 strain to mimic the severe symptoms observed in elderly patients with COVID-19. Comprehensive analyses of the whole lung were performed using transcriptome and proteome sequencing, comparing data from aged and young mice. For transcriptome analysis, bulk RNA sequencing was conducted using an Illumina sequencing platform. Proteomic analysis was performed using mass spectrometry following protein extraction, digestion, and peptide labelling. We analysed the transcriptome and proteome profiles of young and aged mice and discovered that aged mice exhibited elevated baseline levels of inflammation and tissue damage repair. After SARS-CoV-2 infection, aged mice showed increased antiviral and inflammatory responses; however, these responses were weaker than those in young mice, with significant complement and coagulation cascade responses. In summary, our study demonstrates that the increased vulnerability of the elderly to severe COVID-19 may be attributed to an attenuated antiviral response and the overactivation of complement and coagulation cascades. Future research on antiviral and inflammatory responses is likely to yield treatments that reduce the severity of viral respiratory diseases in the elderly. |
Author | Lin, Xian Liu, Di Ma, Li Ke, Xianliang Chen, Quanjiao Xu, Meng |
Author_xml | – sequence: 1 givenname: Li orcidid: 0000-0002-0057-3904 surname: Ma fullname: Ma, Li – sequence: 2 givenname: Xian surname: Lin fullname: Lin, Xian – sequence: 3 givenname: Meng surname: Xu fullname: Xu, Meng – sequence: 4 givenname: Xianliang surname: Ke fullname: Ke, Xianliang – sequence: 5 givenname: Di orcidid: 0000-0003-3693-2726 surname: Liu fullname: Liu, Di – sequence: 6 givenname: Quanjiao orcidid: 0000-0001-8716-6510 surname: Chen fullname: Chen, Quanjiao |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40228062$$D View this record in MEDLINE/PubMed |
BookMark | eNpVks1uGyEUhVGVqkndPEIrlt3Y4WcYoJuqctPWUqRs2m4Rw9yZIWIGF8ZR8vbFsR0lLABdzv2OgPMenU1xAoQ-UrKiRJErRgURQlcrRphYsUrJWtI36GJfX4qaqLPTvojO0WXOd6SMStHS9g6dV4QxRWp2gYbrh22IyU89ngfAjY8h9t7ZgEdwg518HjOOHc5wDwnw-vbv5vuSauynJz2EFlJ4_II3U_b9MGfcpThiO2HbQ4vHuMtQ5hbCB_S2syHD5XFdoD8_rn-vfy1vbn9u1t9ulq5ial5a2TiqZc117TordAtUtbUllAuuZCd5w62tdCNaxSghQGvNLbGUgRRUtpov0ObAbaO9M9vkR5seTbTePBVi6o1Ns3cBDJFgmeRUU-sq1WndNEow1nHteEs1K6yvB9Z214zQOpjmZMMr6OuTyQ-mj_eGMkJERWUhfD4SUvy3gzyb0WcHIdgJytuYYk44F6rcb4E-vTR7djn9VRGIg8ClmHOC7llCidnHwpxiYfaxMMdY8P-jd6hC |
Cites_doi | 10.3389/fimmu.2021.714511 10.1001/jamanetworkopen.2023.47318 10.1101/gr.1239303 10.1128/JVI.00964-21 10.1111/jth.14768 10.1126/science.abd7672 10.1126/sciimmunol.abg0833 10.1093/nar/gkv007 10.1111/jth.14817 10.1186/s13059-014-0550-8 10.1038/s41586-019-1365-2 10.1016/S2352-3026(20)30145-9 10.1016/S0140-6736(20)30211-7 10.1126/sciimmunol.abh2259 10.1089/omi.2011.0118 10.1016/j.vaccine.2024.01.082 10.3389/fimmu.2020.01661 10.1128/mBio.01753-18 10.1038/s41426-018-0063-8 10.1016/S0140-6736(20)30183-5 10.1186/s40001-020-00432-3 10.1007/BF03324904 10.1001/jamainternmed.2020.0994 10.1159/000512592 10.1038/s41467-019-09234-6 10.1001/jama.2020.2648 10.1038/s41574-018-0059-4 10.1016/j.chom.2020.05.020 10.1016/j.isci.2021.103215 10.1172/jci.insight.140711 10.1007/s13238-020-00767-x 10.1016/j.ebiom.2021.103381 10.1128/JVI.00127-09 10.1038/ni.1923 10.1080/22221751.2022.2026741 10.1093/bioinformatics/btt656 10.3389/fimmu.2022.821664 10.3390/cells10030708 10.3389/fragi.2022.900028 10.1038/s41467-021-27717-3 10.1093/gigascience/giab008 10.3389/fragi.2022.840827 10.1038/s41586-024-07238-x 10.3389/fimmu.2021.668725 10.1038/s43587-021-00114-7 10.1016/B978-012369454-6/50074-1 10.1128/JVI.01511-21 10.2215/CJN.06230614 10.1016/j.ajic.2020.06.213 10.1093/bioinformatics/btv300 10.3389/fimmu.2021.738073 10.1038/nmeth.3317 10.1101/2024.09.24.614691 10.1016/j.blre.2022.100995 10.1371/journal.pbio.3001284 10.1038/s41591-020-0822-7 10.1371/journal.pone.0247060 10.1126/science.abb8001 10.1093/bioinformatics/bty560 10.1016/j.exger.2019.110632 10.1371/journal.pone.0241824 10.1056/NEJMra0801082 10.1002/jmv.26183 10.3389/fimmu.2022.902206 10.4110/in.2019.19.e37 10.2807/1560-7917.ES.2020.25.26.2001214 10.1038/s41591-022-02156-9 10.3390/vaccines11010047 10.1093/bioinformatics/btw313 |
ContentType | Journal Article |
Copyright | 2025 Chinese Academy of science. Published by Informa UK Limited, trading as Taylor & Francis Group. 2025 Chinese Academy of science |
Copyright_xml | – notice: 2025 Chinese Academy of science. Published by Informa UK Limited, trading as Taylor & Francis Group. 2025 Chinese Academy of science |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA |
DOI | 10.1080/21505594.2025.2487671 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
DocumentTitleAlternate | L. MA ET AL |
EISSN | 2150-5608 |
ExternalDocumentID | oai_doaj_org_article_07ea273191ac48f99bb8522f39c3d192 PMC12005417 40228062 10_1080_21505594_2025_2487671 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- 0YH 53G AAYXX ABDBF ABPEM ACGFS ACUHS ADBBV ADCVX AENEX AIJEM ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION EBS EMOBN ESX F5P GROUPED_DOAJ GTTXZ H13 HZ~ O9- OK1 RPM SV3 TDBHL TFL TFW TR2 TUS 4.4 ABCCY C1A CGR CUY CVF DGEBU DIK ECM EIF EJD HYE M4Z NPM OVD TEORI TTHFI 7X8 5PM |
ID | FETCH-LOGICAL-c428t-a7bc1976396cfa59de18d6a0135387f73b3aa49b5d82100e1693a0a12e7517d93 |
IEDL.DBID | DOA |
ISSN | 2150-5594 2150-5608 |
IngestDate | Wed Aug 27 01:22:45 EDT 2025 Thu Aug 21 18:29:09 EDT 2025 Wed Jul 02 04:58:14 EDT 2025 Wed Aug 06 16:36:22 EDT 2025 Tue Jul 01 05:05:51 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | complement activation SARS-CoV-2 immune response transcriptome aged mice proteome |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c428t-a7bc1976396cfa59de18d6a0135387f73b3aa49b5d82100e1693a0a12e7517d93 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 These authors contributed equally to this work. |
ORCID | 0000-0003-3693-2726 0000-0002-0057-3904 0000-0001-8716-6510 |
OpenAccessLink | https://doaj.org/article/07ea273191ac48f99bb8522f39c3d192 |
PMID | 40228062 |
PQID | 3190335801 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_07ea273191ac48f99bb8522f39c3d192 pubmedcentral_primary_oai_pubmedcentral_nih_gov_12005417 proquest_miscellaneous_3190335801 pubmed_primary_40228062 crossref_primary_10_1080_21505594_2025_2487671 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2025-12-00 |
PublicationDateYYYYMMDD | 2025-12-01 |
PublicationDate_xml | – month: 12 year: 2025 text: 2025-12-00 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Virulence |
PublicationTitleAlternate | Virulence |
PublicationYear | 2025 |
Publisher | Taylor & Francis Taylor & Francis Group |
Publisher_xml | – name: Taylor & Francis – name: Taylor & Francis Group |
References | Kim D (e_1_3_7_34_1) 2015; 12 Vestergaard LS (e_1_3_7_14_1) 2020; 25 e_1_3_7_41_1 e_1_3_7_66_1 e_1_3_7_45_1 e_1_3_7_64_1 e_1_3_7_22_1 e_1_3_7_24_1 e_1_3_7_49_1 Ali YM (e_1_3_7_62_1) 2021; 12 Sun SH (e_1_3_7_25_1) 2020; 28 e_1_3_7_26_1 Alosaimi B (e_1_3_7_63_1) 2021; 12 e_1_3_7_28_1 Chen S (e_1_3_7_33_1) 2018; 34 Franceschi C (e_1_3_7_47_1) 2018; 14 e_1_3_7_70_1 Ross JB (e_1_3_7_53_1) 2024; 628 e_1_3_7_30_1 e_1_3_7_72_1 Flurkey K (e_1_3_7_32_1) 2007 e_1_3_7_55_1 e_1_3_7_11_1 e_1_3_7_13_1 e_1_3_7_36_1 Campisi J (e_1_3_7_48_1) 2019; 571 Huang C (e_1_3_7_57_1) 2020; 395 e_1_3_7_38_1 Dong W (e_1_3_7_6_1) 2022; 96 e_1_3_7_19_1 e_1_3_7_2_1 e_1_3_7_4_1 Ma L (e_1_3_7_60_1) 2021; 6 Liu MY (e_1_3_7_16_1) 2020; 6 e_1_3_7_8_1 Zhou Y (e_1_3_7_44_1) 2019; 10 Bajgain KT (e_1_3_7_51_1) 2021; 49 e_1_3_7_40_1 e_1_3_7_61_1 Java A (e_1_3_7_71_1) 2020; 5 Russell CD (e_1_3_7_9_1) 2023; 29 e_1_3_7_21_1 e_1_3_7_67_1 e_1_3_7_27_1 e_1_3_7_46_1 Lim EHT (e_1_3_7_68_1) 2023; 57 e_1_3_7_29_1 Furie B (e_1_3_7_54_1) 2008; 359 Tang N (e_1_3_7_59_1) 2020; 18 Laxminarayan R (e_1_3_7_7_1) 2020; 370 Maeda M (e_1_3_7_69_1) 2024; 42 Feng E (e_1_3_7_18_1) 2021; 10 Grubeck-Loebenstein B (e_1_3_7_23_1) 2009; 21 Walter W (e_1_3_7_42_1) 2015; 31 Shannon P (e_1_3_7_43_1) 2003; 13 Jiang Y (e_1_3_7_65_1) 2018; 7 e_1_3_7_52_1 e_1_3_7_50_1 e_1_3_7_10_1 Oh SJ (e_1_3_7_20_1) 2019; 19 e_1_3_7_31_1 e_1_3_7_56_1 e_1_3_7_12_1 e_1_3_7_35_1 Kim YI (e_1_3_7_15_1) 2022; 13 e_1_3_7_58_1 e_1_3_7_39_1 e_1_3_7_3_1 e_1_3_7_5_1 R Core Team (e_1_3_7_37_1) 2024 Baker SA (e_1_3_7_17_1) 2021; 16 |
References_xml | – volume: 12 start-page: 714511 year: 2021 ident: e_1_3_7_62_1 article-title: Lectin pathway mediates complement activation by SARS-CoV-2 proteins publication-title: Front Immunol doi: 10.3389/fimmu.2021.714511 – ident: e_1_3_7_3_1 doi: 10.1001/jamanetworkopen.2023.47318 – volume: 13 start-page: 2498 issue: 11 year: 2003 ident: e_1_3_7_43_1 article-title: Cytoscape: a software environment for integrated models of biomolecular interaction networks publication-title: Genome Res doi: 10.1101/gr.1239303 – volume: 96 start-page: e0096421 issue: 1 year: 2022 ident: e_1_3_7_6_1 article-title: The K18-human ACE2 transgenic mouse model recapitulates non-severe and severe COVID-19 in response to an infectious dose of the SARS-CoV-2 virus publication-title: J Virol doi: 10.1128/JVI.00964-21 – ident: e_1_3_7_56_1 doi: 10.1111/jth.14768 – volume: 370 start-page: 691 issue: 6517 year: 2020 ident: e_1_3_7_7_1 article-title: Epidemiology and transmission dynamics of COVID-19 in two Indian states publication-title: Science doi: 10.1126/science.abd7672 – ident: e_1_3_7_67_1 doi: 10.1126/sciimmunol.abg0833 – ident: e_1_3_7_39_1 doi: 10.1093/nar/gkv007 – volume: 18 start-page: 1094 issue: 5 year: 2020 ident: e_1_3_7_59_1 article-title: Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy publication-title: J Thromb Haemost doi: 10.1111/jth.14817 – ident: e_1_3_7_38_1 doi: 10.1186/s13059-014-0550-8 – volume: 571 start-page: 183 issue: 7764 year: 2019 ident: e_1_3_7_48_1 article-title: From discoveries in ageing research to therapeutics for healthy ageing publication-title: Nature doi: 10.1038/s41586-019-1365-2 – ident: e_1_3_7_55_1 doi: 10.1016/S2352-3026(20)30145-9 – ident: e_1_3_7_58_1 doi: 10.1016/S0140-6736(20)30211-7 – volume: 6 start-page: eabh2259 issue: 59 year: 2021 ident: e_1_3_7_60_1 article-title: Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection publication-title: Sci Immunol doi: 10.1126/sciimmunol.abh2259 – ident: e_1_3_7_41_1 doi: 10.1089/omi.2011.0118 – volume: 6 start-page: 98 issue: 2 year: 2020 ident: e_1_3_7_16_1 article-title: Role and mechanism of angiotensin-converting enzyme 2 in acute lung injury in coronavirus disease 2019 publication-title: Chronic Dis Transl Med – volume: 42 start-page: 1542 issue: 7 year: 2024 ident: e_1_3_7_69_1 article-title: The age-specific impact of COVID-19 vaccination on medical expenditures and hospitalization duration after breakthrough infection: the vaccine effectiveness, networking, and universal safety (VENUS) study publication-title: Vaccine doi: 10.1016/j.vaccine.2024.01.082 – ident: e_1_3_7_70_1 doi: 10.3389/fimmu.2020.01661 – ident: e_1_3_7_66_1 doi: 10.1128/mBio.01753-18 – volume: 7 start-page: 77 issue: 1 year: 2018 ident: e_1_3_7_65_1 article-title: Blockade of the C5a-C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV publication-title: Emerg Microbes Infect doi: 10.1038/s41426-018-0063-8 – volume: 395 start-page: 497 issue: 10223 year: 2020 ident: e_1_3_7_57_1 article-title: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China publication-title: Lancet doi: 10.1016/S0140-6736(20)30183-5 – ident: e_1_3_7_4_1 doi: 10.1186/s40001-020-00432-3 – volume-title: R: A language and environment for statistical computing year: 2024 ident: e_1_3_7_37_1 – volume: 21 start-page: 201 issue: 3 year: 2009 ident: e_1_3_7_23_1 article-title: Immunosenescence and vaccine failure in the elderly publication-title: Aging Clin Exp Res doi: 10.1007/BF03324904 – ident: e_1_3_7_50_1 doi: 10.1001/jamainternmed.2020.0994 – ident: e_1_3_7_8_1 doi: 10.1159/000512592 – volume: 10 start-page: 1523 issue: 1 year: 2019 ident: e_1_3_7_44_1 article-title: Metascape provides a biologist-oriented resource for the analysis of systems-level datasets publication-title: Nat Commun doi: 10.1038/s41467-019-09234-6 – ident: e_1_3_7_11_1 doi: 10.1001/jama.2020.2648 – volume: 14 start-page: 576 issue: 10 year: 2018 ident: e_1_3_7_47_1 article-title: Inflammaging: a new immune-metabolic viewpoint for age-related diseases publication-title: Nat Rev Endocrinol doi: 10.1038/s41574-018-0059-4 – volume: 28 start-page: 124 issue: 1 year: 2020 ident: e_1_3_7_25_1 article-title: A mouse model of SARS-CoV-2 infection and pathogenesis publication-title: Cell Host Microbe doi: 10.1016/j.chom.2020.05.020 – ident: e_1_3_7_61_1 doi: 10.1016/j.isci.2021.103215 – volume: 5 start-page: e140711 issue: 15 year: 2020 ident: e_1_3_7_71_1 article-title: The complement system in COVID-19: friend and foe? publication-title: JCI Insight doi: 10.1172/jci.insight.140711 – ident: e_1_3_7_28_1 doi: 10.1007/s13238-020-00767-x – ident: e_1_3_7_31_1 doi: 10.1016/j.ebiom.2021.103381 – ident: e_1_3_7_64_1 doi: 10.1128/JVI.00127-09 – ident: e_1_3_7_46_1 doi: 10.1038/ni.1923 – ident: e_1_3_7_26_1 doi: 10.1080/22221751.2022.2026741 – ident: e_1_3_7_36_1 doi: 10.1093/bioinformatics/btt656 – ident: e_1_3_7_29_1 doi: 10.3389/fimmu.2022.821664 – volume: 10 start-page: 708 issue: 3 year: 2021 ident: e_1_3_7_18_1 article-title: Aging and interferons: impacts on inflammation and viral disease outcomes publication-title: Cells doi: 10.3390/cells10030708 – ident: e_1_3_7_22_1 doi: 10.3389/fragi.2022.900028 – volume: 13 start-page: 21 issue: 1 year: 2022 ident: e_1_3_7_15_1 article-title: Age-dependent pathogenic characteristics of SARS-CoV-2 infection in ferrets publication-title: Nat Commun doi: 10.1038/s41467-021-27717-3 – ident: e_1_3_7_35_1 doi: 10.1093/gigascience/giab008 – ident: e_1_3_7_19_1 doi: 10.3389/fragi.2022.840827 – volume: 628 start-page: 162 issue: 8006 year: 2024 ident: e_1_3_7_53_1 article-title: Depleting myeloid-biased haematopoietic stem cells rejuvenates aged immunity publication-title: Nature doi: 10.1038/s41586-024-07238-x – volume: 12 start-page: 668725 year: 2021 ident: e_1_3_7_63_1 article-title: Complement anaphylatoxins and inflammatory cytokines as prognostic markers for COVID-19 severity and In-hospital mortality publication-title: Front Immunol doi: 10.3389/fimmu.2021.668725 – ident: e_1_3_7_49_1 doi: 10.1038/s43587-021-00114-7 – start-page: 637 volume-title: The mouse in biomedical research year: 2007 ident: e_1_3_7_32_1 doi: 10.1016/B978-012369454-6/50074-1 – ident: e_1_3_7_24_1 doi: 10.1128/JVI.01511-21 – ident: e_1_3_7_45_1 doi: 10.2215/CJN.06230614 – volume: 49 start-page: 238 issue: 2 year: 2021 ident: e_1_3_7_51_1 article-title: Prevalence of comorbidities among individuals with COVID-19: a rapid review of current literature publication-title: Am J Infect Control doi: 10.1016/j.ajic.2020.06.213 – volume: 31 start-page: 2912 issue: 17 year: 2015 ident: e_1_3_7_42_1 article-title: Goplot: an R package for visually combining expression data with functional analysis publication-title: Bioinformatics doi: 10.1093/bioinformatics/btv300 – ident: e_1_3_7_5_1 doi: 10.3389/fimmu.2021.738073 – volume: 12 start-page: 357 issue: 4 year: 2015 ident: e_1_3_7_34_1 article-title: HISAT: a fast spliced aligner with low memory requirements publication-title: Nat Methods doi: 10.1038/nmeth.3317 – ident: e_1_3_7_72_1 doi: 10.1101/2024.09.24.614691 – volume: 57 start-page: 100995 year: 2023 ident: e_1_3_7_68_1 article-title: Complement activation in COVID-19 and targeted therapeutic options: a scoping review publication-title: Blood Rev doi: 10.1016/j.blre.2022.100995 – ident: e_1_3_7_27_1 doi: 10.1371/journal.pbio.3001284 – ident: e_1_3_7_12_1 doi: 10.1038/s41591-020-0822-7 – volume: 16 start-page: e0247060 issue: 2 year: 2021 ident: e_1_3_7_17_1 article-title: Angiotensin-converting enzyme 2 (ACE2) expression increases with age in patients requiring mechanical ventilation publication-title: PLOS ONE doi: 10.1371/journal.pone.0247060 – ident: e_1_3_7_13_1 doi: 10.1126/science.abb8001 – volume: 34 start-page: i884 issue: 17 year: 2018 ident: e_1_3_7_33_1 article-title: Fastp: an ultra-fast all-in-one FASTQ preprocessor publication-title: Bioinformatics doi: 10.1093/bioinformatics/bty560 – ident: e_1_3_7_21_1 doi: 10.1016/j.exger.2019.110632 – ident: e_1_3_7_52_1 doi: 10.1371/journal.pone.0241824 – volume: 359 start-page: 938 issue: 9 year: 2008 ident: e_1_3_7_54_1 article-title: Mechanisms of thrombus formation publication-title: N Engl J Med doi: 10.1056/NEJMra0801082 – ident: e_1_3_7_10_1 doi: 10.1002/jmv.26183 – ident: e_1_3_7_2_1 doi: 10.3389/fimmu.2022.902206 – volume: 19 start-page: e37 issue: 6 year: 2019 ident: e_1_3_7_20_1 article-title: Aging and the immune system: the impact of immunosenescence on viral infection, immunity and vaccine immunogenicity publication-title: Immune Netw doi: 10.4110/in.2019.19.e37 – volume: 25 start-page: 2001214 issue: 26 year: 2020 ident: e_1_3_7_14_1 article-title: Excess all-cause mortality during the COVID-19 pandemic in Europe - preliminary pooled estimates from the EuroMOMO network, March to April 2020 publication-title: Euro Surveill doi: 10.2807/1560-7917.ES.2020.25.26.2001214 – volume: 29 start-page: 334 issue: 2 year: 2023 ident: e_1_3_7_9_1 article-title: Comorbidities, multimorbidity and COVID-19 publication-title: Nat Med doi: 10.1038/s41591-022-02156-9 – ident: e_1_3_7_30_1 doi: 10.3390/vaccines11010047 – ident: e_1_3_7_40_1 doi: 10.1093/bioinformatics/btw313 |
SSID | ssj0000481055 |
Score | 2.3898478 |
Snippet | The elderly population, who have increased susceptibility to severe outcomes, have been particularly impacted by the coronavirus disease 2019 (COVID-19) caused... |
SourceID | doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 2487671 |
SubjectTerms | Age Factors Aged aged mice Aging Animals complement activation COVID-19 - immunology COVID-19 - pathology COVID-19 - virology Disease Models, Animal Female Gene Expression Profiling Humans immune response Lung - immunology Lung - pathology Lung - virology Male Mice Mice, Inbred C57BL Proteome Proteomics SARS-CoV-2 SARS-CoV-2 - pathogenicity Transcriptome |
Title | Exploring the biological mechanisms of severe COVID-19 in the elderly: Insights from an aged mouse model |
URI | https://www.ncbi.nlm.nih.gov/pubmed/40228062 https://www.proquest.com/docview/3190335801 https://pubmed.ncbi.nlm.nih.gov/PMC12005417 https://doaj.org/article/07ea273191ac48f99bb8522f39c3d192 |
Volume | 16 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3dS8MwEA86EHwRv50fI4Kv3ZombRrfdDo2QX1xMp9K2qQ4cJ2s82H_vXdtN1YRfPE1TUi4S3O_S-5-R8gVQAQDwFw7yCXmCJkKR2MWiGHCKmT8UgzznR-fgv5QPIz80VqpL4wJK-mBS8F1XGk1mFhwK3QiwlSpOA4BM6RcJdwAPMHTF2zemjNVnMEixMqPWFkOEI8DsFks03dCt4Nt2ATuoee3PcDsgWQ1w1Tw9_8GOn_GTq4Zo94u2alQJL0pV79HNmy2T7bKupKLA_K-iqyjgO9oSbSE2qATi5m-43yS02lKwSramaXd59fBncMUHWdFf4uVuz8W13SQ5ei75xSTUKjOKBw-huJlgaVFCZ1DMuzdv3T7TlVSwUnAz5g7WsYJAwTCVZCk2lfGstAE2sXqF6FMJY-51kLFvgnBF3QtUrVoVzPPSp9Jo_gRaWTTzJ4QypTlifRjLj18E4aDgDPBTOAlxpeulU3SXsoz-iyZMyJWEZIuFRChAqJKAU1yi1JfdUbi66IBtkNUbYfor-3QJJdLnUXwo-Drh84syCWCMS7HR1-Y6LjU4WoqUbACBTA6rGm3tpb6l2z8XpBxM7yWE0ye_sfqz8g2SqQMlzknjfnsy14A6JnHLbLpvvVbxS7_Bp1t-Ck |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Exploring+the+biological+mechanisms+of+severe+COVID-19+in+the+elderly%3A+Insights+from+an+aged+mouse+model&rft.jtitle=Virulence&rft.au=Ma%2C+Li&rft.au=Lin%2C+Xian&rft.au=Xu%2C+Meng&rft.au=Ke%2C+Xianliang&rft.date=2025-12-01&rft.issn=2150-5608&rft.eissn=2150-5608&rft.volume=16&rft.issue=1&rft.spage=2487671&rft_id=info:doi/10.1080%2F21505594.2025.2487671&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2150-5594&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2150-5594&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2150-5594&client=summon |